
Rae Yeung, MD, PhD, and others from the Understanding Childhood Arthritis Network’s Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases will outline new developments in juvenile idiopathic arthritis (JIA) facilitated by a team science approach to translational research.
Thought leader Tait Shanafelt, MD, shared strategies for combating occupational distress and burnout, including ongoing development and support for a health system’s leaders and collaborative action planning at the individual unit level.
George C. Tsokos, MD, will discuss how the current understanding of the pathogenesis of systemic lupus erythematous has evolved over time and where future directions in research might lead.
Justin Oldham, MD, PhD, will discuss monitoring and multidisciplinary care for progressive pulmonary fibrosis in patients with rheumatic disease, and Erin Wilfong, MD, PhD, will explore combining clinical and biological features of interstitial lung disease to improve disease management.
Hermine I. Brunner, MD, MSc, MBA, and Emily von Scheven, MD, MAS, will explore the arguments for and against different approaches to corticosteroid use in pediatric patients with systemic lupus erythematous.
Featuring four cases apiece, each of these interactive sessions will explain how to arrive at the correct diagnosis when confronted with mimickers of common diseases, unusual genetic disorders, or an overlay of diseases.
Using a case-based format, Lisa Sammaritano, MD, and other panelists will demonstrate how to use the guideline in a clinical setting, highlighting updates for 2025, and describe how the new recommendations were developed.
Panelists, including Jin Kyun Park, MD, will discuss vaccine response in immunocompromised patients and vaccines as preventative care for those patients.
Jose U. Scher, MD, will discuss challenges associated with addressing early onset psoriatic arthritis (PsA). The session also will review therapies for managing PsA.
Presentations in this Sunday session will include an assessment of the latest advances in better understanding the multiple phenotypes of pulmonary sarcoidosis from Michelle Sharp, MD, MHS.